Cardiology
News
COVID-19: How intensive care cardiology can inform the response
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
News
Protean manifestations of COVID-19: “Our ignorance is profound”
“Make sure they didn’t die in vain.”
News
Evidence suggests possible RAS-blocker benefit in COVID-19 patients
...
News
No hydroxychloroquine benefit in small, randomized COVID-19 trial
Two experts caution that because of confounding, the trial is unable to answer convincingly the question of whether HCQ can benefit COVID-19...
Opinion
COVID-19 mythconceptions
We are in a position where we need to take in what we can and assess the best data available.
News
Sodium nitrite disappoints in cardiac arrest
News
COVID-19 cases highlight longstanding racial disparities in health care
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
News
Troponins touted as ‘ally’ in COVID-19 triage, but message is nuanced
A consequence of not measuring hs-cTn may be to “ignore the plethora of ischemic and nonischemic causes of myocardial injury related to COVID-19...
News
Cardiology groups push back on hydroxychloroquine, azithromycin for COVID-19
Both drugs are known to cause torsade de pointes and increase the risk of other arrhythmias, say the AHA, ACC, and HRS.